Andrew Witty

Andrew Witty was named chief executive officer of UnitedHealth Group in February 2021. As UnitedHealth Group CEO, Witty is responsible for the strategic direction and overall performance of the enterprise and its long-term growth agenda. He is also a member of the UnitedHealth Group Board of Directors. Witty was named executive vice president of UnitedHealth Group, and CEO of Optum, in March 2018 and previously served as a UnitedHealth Group company director.

From 2008 to 2017, Witty was CEO and a director of the leading pharmaceutical manufacturer GlaxoSmithKline plc (GSK). He joined GSK in 1985, and prior to being named CEO, served as president of GSK Europe.

Witty is former chancellor of the University of Nottingham, a British public research university, and serves on the Singapore Prime Minister’s Research, Innovation and Enterprise Council. He became chair, Imperial College Business School Advisory Board in November 2020. Between April and December 2020, Witty took an unpaid leave as special envoy at the World Health Organization, co-leading the effort to accelerate responses to COVID-19.

Witty was knighted in 2012 for services to the U.K. economy. In 2017, he was named an honorary citizen by Singapore for his contributions to the country’s growth and development. He earned honorary degrees from Exeter, Manchester and Nottingham Universities.